Sarah Verhoeff

[89Zr]Zr-DFO-avelumab PET/CT in early-stage non-small cell lung carcinoma patients to predict neo-adjuvant avelumab treatment response Sarah R. Verhoeff, Erik H.J.G. Aarntzen, Evelien van Genugten, Shoko Vos, Lieke van der Woude, Carla M.L. van Herpen, Ad Verhagen, Berber Piet, Sandra Heskamp, Michel van den Heuvel Manuscript in preparation

RkJQdWJsaXNoZXIy MTk4NDMw